Ovid Therapeutics

Ovid Therapeutics, founded in 2014 in New York, USA, is a biopharmaceutical company dedicated to developing treatments for patients with rare neurological disorders. Our deep understanding of human genetics and cellular function enables us to translate discoveries into meaningful therapies for rare neurological conditions.